Close

MST1R

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

This gene encodes a cell surface receptor for macrophage-stimulating protein (MSP) with tyrosine kinase activity. The mature form of this protein is a heterodimer of disulfide-linked alpha and beta subunits, generated by proteolytic cleavage of a single-chain precursor. The beta subunit undergoes tyrosine phosphorylation upon stimulation by MSP. This protein is expressed on the ciliated epithelia of the mucociliary transport apparatus of the lung, and together with MSP, thought to be involved in host defense. Alternative splicing generates multiple transcript variants encoding different isoforms that may undergo similar proteolytic processing.
  • CAR Vector Products

  • AbTCR Vector Products

  • DMAb

Loading...
  • Target Species:
  • Antibody Clone:
  • Antibody Host:
  • Receptor Construction:
  • Vector Type:
  • Targeting Cell Type:
CAT Product Name Target Species Antibody Clone Antibody Host Receptor Construction Vector Type Targeting Cell Type CAR Vector Type Inquiry & Datasheet
CAR-WFY2435 Anti-MST1R (RON6) h(41BB-CD3ζ) CAR, pCDCAR1 Human RON6 Mouse scFv-41BB-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-WFY2436 Anti-MST1R (1P3B2.2) h(41BB-CD3ζ) CAR, pCDCAR1 Human 1P3B2.2 Mouse scFv-41BB-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-WFY2437 Anti-MST1R (M93-D02) h(41BB-CD3ζ) CAR, pCDCAR1 Human M93-D02 Mouse scFv-41BB-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-WFY2438 Anti-MST1R (1P4A3.3) h(41BB-CD3ζ) CAR, pCDCAR1 Human 1P4A3.3 Mouse scFv-41BB-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-WFY2439 Anti-MST1R (AB034) h(41BB-CD3ζ) CAR, pCDCAR1 Human AB034 Mouse scFv-41BB-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-WFY2440 Anti-MST1R (MOR07923) h(41BB-CD3ζ) CAR, pCDCAR1 Human MOR07923 Human scFv-41BB-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-WFY3155 Anti-MST1R (4C04) h(41BB-CD3ζ) CAR, pCDCAR1 Human 4C04 Mouse scFv-41BB-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-WFY5688 Anti-MST1R (RON6) h(CD28-CD3ζ) CAR, pCDCAR1 Human RON6 Mouse scFv-CD28-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-WFY5689 Anti-MST1R (1P3B2.2) h(CD28-CD3ζ) CAR, pCDCAR1 Human 1P3B2.2 Mouse scFv-CD28-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-WFY5690 Anti-MST1R (M93-D02) h(CD28-CD3ζ) CAR, pCDCAR1 Human M93-D02 Mouse scFv-CD28-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-WFY5691 Anti-MST1R (1P4A3.3) h(CD28-CD3ζ) CAR, pCDCAR1 Human 1P4A3.3 Mouse scFv-CD28-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-WFY5692 Anti-MST1R (AB034) h(CD28-CD3ζ) CAR, pCDCAR1 Human AB034 Mouse scFv-CD28-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-WFY5693 Anti-MST1R (MOR07923) h(CD28-CD3ζ) CAR, pCDCAR1 Human MOR07923 Human scFv-CD28-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-WFY6408 Anti-MST1R (4C04) h(CD28-CD3ζ) CAR, pCDCAR1 Human 4C04 Mouse scFv-CD28-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
Unable to find the desired product? Explore the Filter Options at the top of the list.
Key Updates
Newsletter NEWSLETTER

The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders

LEARN MORE NEWSLETTER
New Solution NEW SOLUTION

CellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.

LEARN MORE SOLUTION
NOVEL SOLUTION NOVEL TECHNOLOGY

Silence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.

LEARN MORE NOVEL TECHNOLOGY
NEW TECHNOLOGY NEW SOLUTION

Canine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.

LEARN MORE SOLUTION
Receive our latest news and insights.